Skip to Content

We invite you to try out our new beta eCFR site at We’ve made big changes to make the eCFR easier to use. Be sure to leave feedback using the 'Feedback' button on the bottom right of each page!


Notice Pursuant to the National Cooperative Research and Production Act of 1993-Pistoia Alliance, Inc.

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Notice is hereby given that, on November 29, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, Start Printed Page 118415 U.S.C. 4301 et seq. (“the Act”), Pistoia Alliance, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, American Society of Clinical Oncology, Alexandria, VA; Richard Norman (individual member), Gjoik, NORWAY; The Cure Parkinson's Trust, London, UNITED KINGDOM; Zofia Jordan (individual member), Welwyn Garden City, UNITED KINGDOM; Thermo Fisher Scientific, Waltham, MA; Arctoris Ltd., Oxford, UNITED KINGDOM; Statice GmbH, Berlin, GERMANY; Valtari Bio Inc., Austin, TX; LabVoice, Durham, NC; and Nick Juty (individual member), Manchester, UNITED KINGDOM, have been added as parties to this venture.

Also, Clarity Genomics BVBA, Berse, BELGIUM; uFraction8 Ltd., Falkirk, UNITED KINGDOM; Genialis Inc., Houston, TX; Devendra Deshmukh (individual member), Shrewsbury, MA; Envision Biotechnology Inc., Grandsville, MI; MediSapiens Ltd., Helsinki, FINLAND; and Pharmacelera, Sant Cugat del Valles, SPAIN, have withdrawn as parties to this venture.

No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Pistoia Alliance, Inc. intends to file additional written notifications disclosing all changes in membership.

On May 28, 2009, Pistoia Alliance, Inc. filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on July 15, 2009 (74 FR 34364).

The last notification was filed with the Department on September 10, 2019. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on October 17, 2019 (84 FR 55586).

Start Signature

Suzanne Morris,

Chief, Premerger and Division Statistics Unit, Antitrust Division.

End Signature End Preamble

[FR Doc. 2020-00154 Filed 1-8-20; 8:45 am]